Progetto Odin

30/10/2019

30/10/2019

21/05/2018

Corso FAD da 45 crediti ECM online fino al 31 dicembre 2018

06/09/2017

Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study

Sorafenib is currently the only Food and Drug Administration–approved first-line therapy for patients with advanced hepatocellular carcinoma. There are few data examining how sorafenib starting dose...

06/09/2017

The Lipid Kinase PIKfyve Coordinates the Neutrophil Immune Response through the Activation of the Rac GTPase [INNATE IMMUNITY AND INFLAMMATION]

Abstract

04/09/2017

Dynamic Molecular Analysis and Clinical Correlates of Tumor Evolution Within a Phase 2 Trial of Panitumumab-Based Therapy in Metastatic Colorectal Cancer

Background: Mutations in rat sarcoma (RAS) genes may be a mechanism of secondary resistance in EGFR inhibitor−treated patients. Tumor-tissue biopsy testing has been the standard for evaluating mutational...

03/09/2017

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Supported by Cancer Research U.K. (CRUK_A12459), Medical Research Council (MRC_MC_UU_12023/25), Astellas Pharma, Clovis Oncology, Janssen, Novartis, Pfizer, and Sanofi-Aventis.

02/09/2017

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma

To evaluate the impact of the addition of bortezomib to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) on outcomes in previously untreated patients with non–germinal...

02/09/2017

Breast Mass Discovered in 49-Year-Old Patient https://buff.ly/2eMtOhT

01/09/2017

EHR Vendors Seek Clarity from CMS

Welcome to Practice Rounds, our weekly column exploring what’s being covered in the larger world of healthcare.

31/08/2017

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

Endoxifen is a tamoxifen metabolite with potent antiestrogenic activity.

31/08/2017

Risk of Alzheimer’s Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer

To assess the relative risk of Alzheimer’s disease (AD) among patients with prostate cancer who received androgen deprivation therapy (ADT), after adjustment for other cancer therapies.

30/08/2017

Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer

The Osimertinib First Time in Patients Ascending Dose (AURA) study (ClinicalTrials.gov identifier: NCT01802632) included two cohorts of treatment-naïve patients to examine clinical activity and safety...

26/08/2017

Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer http://progettoodin.luc/adjuvant-endocrine-therapy-in-postmenopausal-breast-cancer

26/08/2017

Breast Implants Linked to Anaplastic Large-Cell Lymphoma

Today we are discussing the association between certain kinds of breast implants and an increased risk of a rare type of non-Hodgkin T-cell lymphoma known as anaplastic large-cell lymphoma (ALCL), with...

25/08/2017

Case 25-2017: A 45-Year-Old Man with Headache, Fever, and Lymphadenopathy http://progettoodin.luc/case-25-2017-a-45-year-old-man-with-headache-fever-and-lymphadenopathy

25/08/2017

Early Palliative Care Decreased Healthcare Use at End of Life

Participating in a palliative care consultation significantly decreased healthcare use of Medicare beneficiaries with advanced cancer at the end of life, according to the results of a study published...

24/08/2017

Curative, Life‐Extending, and Palliative Chemotherapy: New Outcomes Need New Names http://progettoodin.luc/curative-life%e2%80%90extending-and-palliative-chemotherapy-new-outcomes-need-new-names